Literature DB >> 21441643

[Ketogenic diet for intractable childhood epilepsy; as an early option as well as a last resort].

Susumu Ito1, Hirokazu Oguni.   

Abstract

Since the 1920s, a ketogenic diet, of low-carbohydrate, adequate-protein and high-fat content, has been used for the treatment of intractable childhood epilepsy. A decade ago this diet was tried as a last resort in the treatment of intractable epilepsy. However, recent advances in ketogenic diet have enabled it to become more commonly used worldwide even early in the course of epilepsy. Two less-restrictive ketogenic diets, namely, the modified Atkins diet and low-glycemic-index treatment, have been developed. These diets allow the patients and their families to choose a more liberal menu. Furthermore, a randomized controlled trial found that the ketogenic diet has a significant benefit, which strengthens the supportive evidence. Recently, an international consensus statement guiding optimal clinical management has been published, allowing clinicians to provide standardized treatment. There has also been increased interest in investigating the mechanisms of action of ketogenic diet using various experimental models. The authors review the history, efficacy, side effects, and possible mechanisms underlying the ketogenic diet, as well as the experience with the ketogenic diet at Tokyo Women's Medical University.

Entities:  

Mesh:

Year:  2011        PMID: 21441643

Source DB:  PubMed          Journal:  Brain Nerve        ISSN: 1881-6096


  2 in total

Review 1.  Diabetes and epilepsy in children and adolescents.

Authors:  M Loredana Marcovecchio; Marianna Immacolata Petrosino; Francesco Chiarelli
Journal:  Curr Diab Rep       Date:  2015-04       Impact factor: 4.810

2.  Epilepsy with myoclonic-atonic seizures (Doose syndrome): When video-EEG polygraphy holds the key to syndrome diagnosis.

Authors:  Pinelopi Dragoumi; Fiona Chivers; Megan Brady; Sheila Craft; David Mushati; Gopalakrishnan Venkatachalam; Judith Helen Cross; Krishna B Das
Journal:  Epilepsy Behav Case Rep       Date:  2015-10-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.